- $10.08bn
- $10.67bn
- $1.27bn
Brief: Spruce Point Capital Management Announces Investment Opinion
Tempus AI Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Tempus Announces Acquisition Of Deep 6 Ai
Tempus AI falls on quarterly revenue miss
Tempus AI Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Tempus AI Quarterly Revenue Increases 35.8% YoY To $200.7 Million
Tempus AI Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Tempus Completes Acquisition Of Ambry Genetics
Brief: Tempus One Introduces New GenAI Capabilities to Query Millions of Unstructured Documents for Research and Clinical Care
Tempus AI drops after Stifel cuts to 'hold' from 'buy'
Brief: Tempus Announces The Clinical Launch Of Its Immune Profile Score Algorithmic Test
Brief: Tempus Announces Real World Data Collaboration With BioNTech
Tempus AI up after brokerages initiate with bullish ratings
Tempus AI up after brokerages initiate with bullish ratings
SoftBank-backed Tempus AI jumps 18% in strong Nasdaq debut
SoftBank-backed Tempus AI jumps as much as 15% in Nasdaq debut
Brief: Tempus Says Pricing Of Its Initial Public Offering Of 11.1 Million Shares Of Class A Common Stock At Public Offering Price Of $37.00/Shr
Tempus AI seeks up to $6.1 bln valuation in US IPO (updated)
Tempus AI aims to raise up to $410.7 mln in US IPO